Earlier blood-test detection could help identify pancreatic cancer patients who need more aggressive treatment, an expert ...

The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage ...

Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...

Zydus Lifesciences and Apollo Hospitals are rolling out Shield MCD in India for eligible adults aged 45 and above. The launch ...

India launches a single blood test screening for 10 cancers, improving early detection while complementing - not replacing - ...

Northwestern Medicine scientists have demonstrated that a highly sensitive blood test can detect traces of pancreatic cancer ...

A new study suggests the investigational Stockholm3 blood test may improve the early detection of aggressive prostate cancer ...

A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at ...

A new blood test detects pancreatic cancer in 65% of patients, up from 17% with the previous test. Northwestern Medicine ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield™ blood test for colorectal cancer screening (CRC) is now covered for eligible UnitedHealth Group ...

Apollo Cancer Centres launches Shield™ Multi-Cancer Detection, a blood-based test that can detect signs of multiple cancers ...